Status | Study |
Terminated |
Study Name: Safety and Efficacy of Adipose Derived Stem Cells in Refractory Rheumatoid Arthritis, Systemic Lupus Erythematosus or Sharp's Syndrome Condition: Systemic Lupus Erythematosus Rheumatoid Arthritis Date: 2016-04-06 Interventions: Other: Intravenous injection of Stromal Vascular Fraction Cells (SVF) contai |
Not yet recruiting |
Study Name: Role of Mesenchymal Stem Cells in Fat Grafting Condition: Romberg's Disease Craniofacial Microsomia Lipodystrophy Date: 2015-07-04 Interventions: Procedure: Fat graft enriched with ex vivo expanded stem cells |
Recruiting |
Study Name: Rituximab Versus Cyclophosphamide in Connective Tissue Disease-ILD Condition: Interstitial Lung Disease Scleroderma Idiopathic Inflammat Date: 2013-05-22 Interventions: Drug: Rituximab Drug: Cyclophosphamide |
Completed |
Study Name: The CARRA Registry Condition: Juvenile Idiopathic Arthritis Systemic Lupus Erythematosus Date: 2012-09-28 |
Terminated |
Study Name: A Clinical Trial for CTD-ILD Treatment Condition: Interstitial Lung Disease Connective Tissue Disease Date: 2011-08-24 Interventions: Drug: N-Acetylcysteine 600mg by mouth, three times daily for 12 months |
Active, not recruiting |
Study Name: Auto-immunity and Pulmonary Arterial Hypertension Condition: Pulmonary Arterial Hypertension HIV Infection Congenital H Date: 2010-07-12 Interventions: Procedure: skin biopsy The bio |
Recruiting |
Study Name: Characteristics and Disease Progression of Mixed Connective Tissue Disease and Systemic Lupus Erythematosus Condition: Mixed Connective Tissue Disease (MCTD) Systemic Lupus Erythemat Date: 2007-12-19 |
Completed |
Study Name: CLUE Study: Connective Tissue Disease Leg Ulcer Etiology Study Condition: Connective Tissue Diseases Blood Coagulation Disorders Leg Date: 2007-08-28 |
Completed |
Study Name: Alendronate Osteoporosis Study Condition: Glucocorticoid-Associated Osteopenia and Osteoporosis Date: 2005-07-07 Interventions: Drug: Alendronate |
Completed |
Study Name: Safety and Efficacy of Pletal (Cilostazol) for the Treatment of Juvenile Primary and Secondary Raynaud’s Phenomenon Condition: Raynaud's Disease Date: 2002-11-07 Interventions: Drug: Pletal |